tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Guanze Medical Reports Improved Interim Profits Despite Revenue Decline

Story Highlights
Guanze Medical Reports Improved Interim Profits Despite Revenue Decline

Meet Your ETF AI Analyst

An update from Guanze Medical Information Industry (Holding) Co., Ltd. ( (HK:2427) ) is now available.

Guanze Medical Information Industry (Holding) Co., Ltd. reported its unaudited interim results for the six months ended June 30, 2025, showing a decrease in revenue from RMB 40,030,000 in 2024 to RMB 31,855,000 in 2025. Despite this, the company achieved a profit of RMB 3,438,000, a significant improvement from a loss of RMB 137,000 in the previous year, indicating a positive shift in financial performance.

More about Guanze Medical Information Industry (Holding) Co., Ltd.

Guanze Medical Information Industry (Holding) Co., Ltd. operates in the medical information industry, focusing on the development and provision of medical information services and products.

Average Trading Volume: 356,388

Technical Sentiment Signal: Buy

See more insights into 2427 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1